Advanced therapeutics encompass innovative and complex therapeutic modalities designed to address unmet medical needs and transform patient care. These next‑generation therapies include cell and gene therapies, vaccines, biosimilars and antibody‑drug conjugates (ADCs), all requiring highly specialised analytical and bioanalytical expertise.

Due to their biological complexity and regulatory challenges, advanced therapeutics demand robust, sensitive and compliant testing strategies throughout preclinical and clinical development. Advanced therapeutics services support the development of these modalities by delivering high‑quality data, scientific expertise and regulatory‑compliant solutions, enabling confident decision‑making and accelerating drug development.